The role of postoperative radiation therapy for endometrial cancer: Executive summary of an American society for radiation oncology evidence-based guideline

Practical Radiation Oncology

Volumn 4, Issue 3, 2014, Pages 137-144

  Klopp, Ann ^a   Smith, Benjamin D ^a   Alektiar, Kaled ^b   Cabrera, Alvin ^c   Damato, Antonio L ^d   Erickson, Beth ^e   Fleming, Gini ^f   Gaffney, David ^g   Greven, Kathryn ^h   Lu, Karen ^a   Miller, David ⁱ   Moore, David ^j   Petereit, Daniel ^k   Schefter, Tracey ^l   Small, William ^m   Yashar, Catheryn ⁿ   Viswanathan, Akila N ^d  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

^g UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^h WAKE FOREST SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^j Franciscan Alliance   (United States)

^k Regional Cancer Care Institute   (United States)

^l UNIVERSITY OF COLORADO   (United States)

^m LOYOLA UNIVERSITY CHICAGO   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER GRADING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; ENDOMETRIUM CANCER; EVIDENCE BASED MEDICINE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HIGH RISK PATIENT; HUMAN; HYSTERECTOMY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK REDUCTION; SURVIVAL RATE; TREATMENT INDICATION; ADJUVANT THERAPY; ENDOMETRIAL NEOPLASMS; ONCOLOGY; PATHOLOGY; POSTOPERATIVE PERIOD; RADIATION DOSE; STANDARDS;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; POSTOPERATIVE PERIOD; QUALITY OF LIFE; RADIATION ONCOLOGY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT;

EID: 84898812959     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2014.01.003     Document Type: Article

References (29)

1. Loblaw D.A., Prestrud A.A., Somerfield M.R., et al. American Society of Clinical Oncology Clinical Practice Guidelines: Formal systematic review-based consensus methodology. J Clin Oncol 2012, 30:3136-3140.
2. Sorbe B., Nordström B., Mäenpää J., et al. Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: A controlled randomized study. Int J Gynecol Cancer 2009, 19:873-878.
3. Creutzberg C.L., van Putten W.L., Koper P.C., et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000, 355:1404-1411.
4. Sorbe B., Straumits A., Karlsson L. Intravaginal high-dose-rate brachytherapy for stage I endometrial cancer: A randomized study of two dose-per-fraction levels. Int J Radiat Oncol Biol Phys 2005, 62:1385-1389.
5. Townamchai K., Lee L., Viswanathan A.N. A novel low dose fractionation regimen for adjuvant vaginal brachytherapy in early stage endometrioid endometrial cancer. Gynecol Oncol 2012, 127:351-355.
6. Small W., Beriwal S., Demanes D.J., et al. American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy. Brachytherapy 2012, 11:58-67.
7. Keys H.M., Roberts J.A., Brunetto V.L., et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study. Gynecol Oncol 2004, 92:744-751.
8. Aalders J., Abeler V., Kolstad P., Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients. Obstet Gynecol 1980, 56:419-427.
9. Nout R.A., Smit V.T., Putter H., et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label, non-inferiority, randomised trial. Lancet 2010, 375:816-823.
10. Sorbe B., Horvath G., Andersson H., Boman K., Lundgren C., Pettersson B. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma-a prospective randomized study. Int J Radiat Oncol Biol Phys 2012, 82:1249-1255.
11. Mundt A.J., Roeske J.C., Lujan A.E., et al. Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies. Gynecol Oncol 2001, 82:456-463.
12. Blake P., Swart A.M., Orton J., et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): Pooled trial results, systematic review, and meta-analysis. Lancet 2009, 373:137-146.
13. Lee C.M., Szabo A., Shrieve D.C., Macdonald O.K., Gaffney D.K. Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. JAMA 2006, 295:389-397.
14. Greven K., Winter K., Underhill K., Fontenesci J., Cooper J., Burke T. Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol Oncol Oct 2006, 103(1):155-159.
15. Homesley H.D., Filiaci V., Gibbons S.K., et al. A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study. Gynecol Oncol Mar 2009, 112(3):543-552.
16. Randall M.E., Filiaci V.L., Muss H., et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group Study. J Clin Oncol 2006, 24:36-44.
17. Maggi R., Lissoni A., Spina F., et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: Results of a randomised trial. Br J Cancer 2006, 95:266-271.
18. Susumu N., Sagae S., Udagawa Y., et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study. Gynecol Oncol 2008, 108:226-233.
19. Randall M.E., Spirtos N.M., Dvoretsky P. Whole abdominal radiotherapy versus combination chemotherapy with doxorubicin and cisplatin in advanced endometrial carcinoma (phase III): Gynecologic Oncology Group Study No. 122. J Natl Cancer Inst Monogr 1995, 19:13-15.
20. Klopp A.H., Jhingran A., Ramondetta L., Lu K., Gershenson D.M., Eifel P.J. Node-positive adenocarcinoma of the endometrium: Outcome and patterns of recurrence with and without external beam irradiation. Gynecol Oncol 2009, 115:6-11.
21. Mundt A.J., McBride R., Rotmensch J., Waggoner S.E., Yamada S.D., Connell P.P. Significant pelvic recurrence in high-risk pathologic stage I-IV endometrial carcinoma patients after adjuvant chemotherapy alone: Implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 2001, 50:1145-1153.
22. Creutzberg C.L., van Putten W.L., Wárlám-Rodenhuis C.C., et al. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: The Postoperative Radiation Therapy in Endometrial Carcinoma Trial. J Clin Oncol 2004, 22:1234-1241.
23. Rossi P.J., Jani A.B., Horowitz I.R., Johnstone P.A. Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: A SEER registry analysis. Int J Radiat Oncol Biol Phys 2008, 70:134-138.
24. Randall M.E., Wilder J., Greven K., Raben M. Role of intracavitary cuff boost after adjuvant external irradiation in early endometrial carcinoma. Int J Radiat Oncol Biol Phys 1990, 19:49-54.
25. Greven K.M., D'Agostino R.B., Lanciano R.M., Corn B.W. Is there a role for a brachytherapy vaginal cuff boost in the adjuvant management of patients with uterine-confined endometrial cancer?. Int J Radiat Oncol Biol Phys 1998, 42:101-104.
26. Scotti V., Borghesi S., Meattini I., et al. Postoperative radiotherapy in stage I/II endometrial cancer: Retrospective analysis of 883 patients treated at the University of Florence. Int J Gynecol Cancer 2010, 20:1540-1548.
27. Greven K., Winter K., Underhill K., Fontenesci J., Cooper J., Burke T. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer. Int J Radiat Oncol Biol Phys 2004, 59:168-173.
28. Hogberg T., Signorelli M., de Oliveira C.F., et al. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer-results from two randomised studies. Eur J Cancer 2010, 46:2422-2431.
29. Alvarez Secord A., Havrilesky L.J., Bae-Jump V., et al. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer. Gynecol Oncol 2007, 107:285-291.